Top News

Cadence Pharmaceuticals Terminates Buyout Option For Incline Therapeutics




San Diego-based Cadence Pharmaceuticals said this morning that it has entered into an agreement to terminate an option it has to acquire Incline Therapeutics. Cadence said it will receive approximately $13M from The Medicines Company to terminate the option, plus approximately $1.5M related to the purchase of Incline by The Medicines Company. Cadence said the move would provide it with non-dilutive capital and a "solid return" on its original investment in Incline.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel